Related Experiment Videos

Absence of noxious effects of selected neuroleptics in dominant-lethal mutagenesis assay

Mutation Research
|March 1, 1979
PubMed

Insights

Four tricyclic neuroleptics were tested for dominant-lethal effects in mice. None induced these effects, even at high doses, suggesting safety for reproductive health.

Area of Science:

  • Pharmacology
  • Toxicology
  • Neuroscience

Background:

  • Tricyclic neuroleptics are commonly prescribed for various neurological and psychiatric conditions.
  • Assessing the reproductive toxicity of these widely used medications is crucial for patient safety.

Purpose of the Study:

  • To evaluate the potential for dominant-lethal effects in mice treated with specific tricyclic neuroleptics.
  • To determine if prothiaden, imipramine, oxyprothepin decanoate, and docloxythepin pose a risk to reproductive health.

Main Methods:

  • A dominant-lethal assay was conducted using male mice.
  • Mice were administered escalating doses of prothiaden, imipramine, oxyprothepin decanoate, and docloxythepin.
  • Male mice were mated with untreated females to assess for dominant-lethal mutations.

Main Results:

  • No dominant-lethal effects were observed for any of the tested neuroleptics, even at supra-clinical doses.
  • A temporary reduction in pregnancy rates was noted with docloxythepin, linked to induced male sedation.
  • Sedation in males did not translate to genotoxic effects on reproductive cells.

Conclusions:

  • The tested tricyclic neuroleptics (prothiaden, imipramine, oxyprothepin decanoate, docloxythepin) do not appear to induce dominant-lethal mutations in mice.
  • Docloxythepin's transient effect on pregnancy is attributed to behavioral sedation, not reproductive toxicity.

Related Concept Videos